398 related articles for article (PubMed ID: 21638102)
1. Role of ACE2 in diastolic and systolic heart failure.
Wang W; Bodiga S; Das SK; Lo J; Patel V; Oudit GY
Heart Fail Rev; 2012 Sep; 17(4-5):683-91. PubMed ID: 21638102
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human angiotensin-converting enzyme 2 as a new renin-angiotensin system peptidase for heart failure therapy.
Oudit GY; Penninger JM
Curr Heart Fail Rep; 2011 Sep; 8(3):176-83. PubMed ID: 21611889
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular protection by angiotensin-converting enzyme 2: a new paradigm.
Ferreira AJ; Hernández Prada JA; Ostrov DA; Raizada MK
Future Cardiol; 2008 Mar; 4(2):175-82. PubMed ID: 19804294
[TBL] [Abstract][Full Text] [Related]
4. Targeting angiotensin-converting enzyme 2 as a new therapeutic target for cardiovascular diseases.
Parajuli N; Ramprasath T; Patel VB; Wang W; Putko B; Mori J; Oudit GY
Can J Physiol Pharmacol; 2014 Jul; 92(7):558-65. PubMed ID: 24861775
[TBL] [Abstract][Full Text] [Related]
5. Manipulating angiotensin metabolism with angiotensin converting enzyme 2 (ACE2) in heart failure.
Patel VB; Putko B; Wang Z; Zhong JC; Oudit GY
Drug Discov Today Ther Strateg; 2012; 9(4):e141-e148. PubMed ID: 32362932
[TBL] [Abstract][Full Text] [Related]
6. ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension.
Mendoza-Torres E; Oyarzún A; Mondaca-Ruff D; Azocar A; Castro PF; Jalil JE; Chiong M; Lavandero S; Ocaranza MP
Ther Adv Cardiovasc Dis; 2015 Aug; 9(4):217-37. PubMed ID: 26275770
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme 2 as a therapeutic target for heart failure.
Chamsi-Pasha MA; Shao Z; Tang WH
Curr Heart Fail Rep; 2014 Mar; 11(1):58-63. PubMed ID: 24293035
[TBL] [Abstract][Full Text] [Related]
8. Role of the ACE2/Angiotensin 1-7 Axis of the Renin-Angiotensin System in Heart Failure.
Patel VB; Zhong JC; Grant MB; Oudit GY
Circ Res; 2016 Apr; 118(8):1313-26. PubMed ID: 27081112
[TBL] [Abstract][Full Text] [Related]
9. [Role of ACE2-Ang (1-7)-Mas receptor axis in heart failure with preserved ejection fraction with hypertension].
Yu J; Wu Y; Zhang Y; Zhang L; Ma Q; Luo X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Jul; 43(7):738-746. PubMed ID: 30124209
[TBL] [Abstract][Full Text] [Related]
10. Physical Exercise and ACE2-Angiotensin-(1-7)-Mas Receptor Axis of the Renin Angiotensin System.
Nunes-Silva A; Rocha GC; Magalhaes DM; Vaz LN; Salviano de Faria MH; Simoes E Silva AC
Protein Pept Lett; 2017 Nov; 24(9):809-816. PubMed ID: 28758593
[TBL] [Abstract][Full Text] [Related]
11. Research Progress on Pulmonary Arterial Hypertension and the Role of the Angiotensin Converting Enzyme 2-Angiotensin-(1-7)-Mas Axis in Pulmonary Arterial Hypertension.
Zhang F; Chen A; Pan Y; Wang X; Xu Y; Desai AA; Tang H; Han Y
Cardiovasc Drugs Ther; 2022 Apr; 36(2):363-370. PubMed ID: 33394361
[TBL] [Abstract][Full Text] [Related]
12. Devil and angel in the renin-angiotensin system: ACE-angiotensin II-AT1 receptor axis vs. ACE2-angiotensin-(1-7)-Mas receptor axis.
Iwai M; Horiuchi M
Hypertens Res; 2009 Jul; 32(7):533-6. PubMed ID: 19461648
[TBL] [Abstract][Full Text] [Related]
13. The angiotensin-converting enzyme 2/angiogenesis-(1-7)/Mas axis confers cardiopulmonary protection against lung fibrosis and pulmonary hypertension.
Shenoy V; Ferreira AJ; Qi Y; Fraga-Silva RA; Díez-Freire C; Dooies A; Jun JY; Sriramula S; Mariappan N; Pourang D; Venugopal CS; Francis J; Reudelhuber T; Santos RA; Patel JM; Raizada MK; Katovich MJ
Am J Respir Crit Care Med; 2010 Oct; 182(8):1065-72. PubMed ID: 20581171
[TBL] [Abstract][Full Text] [Related]
14. ACE2: more of Ang-(1-7) or less Ang II?
Ferrario CM
Curr Opin Nephrol Hypertens; 2011 Jan; 20(1):1-6. PubMed ID: 21045683
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin-converting enzyme 2, angiotensin-(1-7) and Mas: new players of the renin-angiotensin system.
Santos RA; Ferreira AJ; Verano-Braga T; Bader M
J Endocrinol; 2013 Feb; 216(2):R1-R17. PubMed ID: 23092879
[TBL] [Abstract][Full Text] [Related]
16. ACE2: a new target for cardiovascular disease therapeutics.
Raizada MK; Ferreira AJ
J Cardiovasc Pharmacol; 2007 Aug; 50(2):112-9. PubMed ID: 17703127
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin-converting enzyme 2: possible role in hypertension and kidney disease.
Wysocki J; González-Pacheco FR; Batlle D
Curr Hypertens Rep; 2008 Feb; 10(1):70-7. PubMed ID: 18367030
[TBL] [Abstract][Full Text] [Related]
18. ACE2/ANG-(1-7)/Mas pathway in the brain: the axis of good.
Xu P; Sriramula S; Lazartigues E
Am J Physiol Regul Integr Comp Physiol; 2011 Apr; 300(4):R804-17. PubMed ID: 21178125
[TBL] [Abstract][Full Text] [Related]
19. ACE2 of the heart: From angiotensin I to angiotensin (1-7).
Keidar S; Kaplan M; Gamliel-Lazarovich A
Cardiovasc Res; 2007 Feb; 73(3):463-9. PubMed ID: 17049503
[TBL] [Abstract][Full Text] [Related]
20. Is hypertension in African-descent populations contributed to by an imbalance in the activities of the ACE2/Ang-(1-7)/Mas and the ACE/Ang II/AT
Cohall D; Ojeh N; Ferrario CM; Adams OP; Nunez-Smith M
J Renin Angiotensin Aldosterone Syst; 2020; 21(1):1470320320908186. PubMed ID: 32089050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
